Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-038540
Filing Date
2024-08-27
Accepted
2024-08-27 16:34:19
Documents
4
Period of Report
2024-08-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A scheduledef14a_2024.htm DEF 14A 466405
2 chart-230501d8abea4fe0861.jpg GRAPHIC 90306
3 chart-349c77a5b90b482faa8.jpg GRAPHIC 92206
4 proxycardinfoa04.jpg GRAPHIC 5043
  Complete submission text file 0001628280-24-038540.txt   726397
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-11504 | Film No.: 241249561
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)